schliessen

Filtern

 

Bibliotheken

Effect of niacin and etofibrate association on subjects with coronary artery disease and serum high-density lipoprotein cholesterol <35 mg/dl

Niacin treatment (alone) was compared with etofibrate and niacin combination to treat patients with high-density lipoprotein

Journal Title: The American journal of cardiology 1999, Vol.83 (1), p.98-100
Main Author: Spósito, Andrei C
Other Authors: Caramelli, Bruno , Serrano, Carlos V , Mansur, Antonio P , Ramires, Jose A.F
Format: Electronic Article Electronic Article
Language: English
Subjects:
Quelle: Alma/SFX Local Collection
Publisher: United States: Elsevier Inc
ID: ISSN: 0002-9149
Link: https://www.ncbi.nlm.nih.gov/pubmed/10073791
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_crossref_primary_10_1016_S0002_9149_98_00787_5
title: Effect of niacin and etofibrate association on subjects with coronary artery disease and serum high-density lipoprotein cholesterol <35 mg/dl
format: Article
creator:
  • Spósito, Andrei C
  • Caramelli, Bruno
  • Serrano, Carlos V
  • Mansur, Antonio P
  • Ramires, Jose A.F
subjects:
  • Anticholesteremic Agents - administration & dosage
  • Anticholesteremic Agents - therapeutic use
  • Cholesterol, HDL - blood
  • Clofibric Acid - administration & dosage
  • Clofibric Acid - analogs & derivatives
  • Clofibric Acid - therapeutic use
  • Coronary Disease - blood
  • Coronary Disease - drug therapy
  • Delayed-Action Preparations
  • Drug Administration Schedule
  • Drug Synergism
  • Female
  • Humans
  • Lipids - blood
  • Male
  • Middle Aged
  • Niacin - administration & dosage
  • Niacin - therapeutic use
  • Time Factors
  • Treatment Outcome
ispartof: The American journal of cardiology, 1999, Vol.83 (1), p.98-100
description: Niacin treatment (alone) was compared with etofibrate and niacin combination to treat patients with high-density lipoprotein
language: eng
source: Alma/SFX Local Collection
identifier: ISSN: 0002-9149
fulltext: fulltext
issn:
  • 0002-9149
  • 1879-1913
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK1.7968073
LOCALfalse
PrimoNMBib
record
control
sourceidpubmed_cross
recordidTN_cdi_crossref_primary_10_1016_S0002_9149_98_00787_5
sourceformatXML
sourcesystemPC
sourcerecordid10073791
originalsourceidFETCH-LOGICAL-c300t-355cb825c17f621dd010e3eedc3140b3b9be28166434b2fc78cb8b8128edd2cb3
addsrcrecordideNqFkNtKAzEQhoMoWquPoORSL1Yzm-5uFgSR4gkEL9TrkMOsjWw3JUmVPoTvbGxFvBMGhoHvn0k-Qo6AnQGD-vyJMVYWLUzak1acMtaIpqi2yAhE0xbQAt8mo19kj-zH-JZHgKreJXuQed60MCKf112HJlHf0cEp4waqBksx-c7poBJSFaM3TiXnB5orLvVb5iP9cGlGjQ9-UGFFVUiYm3URVcT1johhOacz9zorLA7RpRXt3cIvgk-Yz5iZ7zHmlO_pBa_o_PXc9gdkp1N9xMOfPiYvN9fP07vi4fH2fnr1UBjOWCp4VRktyspA09UlWMuAIUe0hsOEaa5bjaWAup7wiS4704iMawGlQGtLo_mYVJu9JvgYA3ZyEdw8f0QCk9965Vqv_HYnWyHXemWVc8eb3GKp52j_pDY-M3C5ATC__t1hkNE4HAxaF7I2ab3758QXqhuNRg
sourcetypeAggregation Database
isCDItrue
recordtypearticle
display
typearticle
titleEffect of niacin and etofibrate association on subjects with coronary artery disease and serum high-density lipoprotein cholesterol <35 mg/dl
sourceAlma/SFX Local Collection
creatorSpósito, Andrei C ; Caramelli, Bruno ; Serrano, Carlos V ; Mansur, Antonio P ; Ramires, Jose A.F
creatorcontribSpósito, Andrei C ; Caramelli, Bruno ; Serrano, Carlos V ; Mansur, Antonio P ; Ramires, Jose A.F
descriptionNiacin treatment (alone) was compared with etofibrate and niacin combination to treat patients with high-density lipoprotein <35 mg/dl and without hypertriglyceridemia. The niacin and etofibrate combination proved to be safe and increased high-density lipoprotein cholesterol levels to 48%, which was 3 times higher than that obtained with niacin alone.
identifier
0ISSN: 0002-9149
1EISSN: 1879-1913
2DOI: 10.1016/S0002-9149(98)00787-5
3PMID: 10073791
languageeng
publisherUnited States: Elsevier Inc
subjectAnticholesteremic Agents - administration & dosage ; Anticholesteremic Agents - therapeutic use ; Cholesterol, HDL - blood ; Clofibric Acid - administration & dosage ; Clofibric Acid - analogs & derivatives ; Clofibric Acid - therapeutic use ; Coronary Disease - blood ; Coronary Disease - drug therapy ; Delayed-Action Preparations ; Drug Administration Schedule ; Drug Synergism ; Female ; Humans ; Lipids - blood ; Male ; Middle Aged ; Niacin - administration & dosage ; Niacin - therapeutic use ; Time Factors ; Treatment Outcome
ispartofThe American journal of cardiology, 1999, Vol.83 (1), p.98-100
rights1999 Excerpta Medica Inc.
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
thumbnail$$Usyndetics_thumb_exl
backlink$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10073791$$D View this record in MEDLINE/PubMed
search
creatorcontrib
0Spósito, Andrei C
1Caramelli, Bruno
2Serrano, Carlos V
3Mansur, Antonio P
4Ramires, Jose A.F
title
0Effect of niacin and etofibrate association on subjects with coronary artery disease and serum high-density lipoprotein cholesterol <35 mg/dl
1The American journal of cardiology
addtitleAm J Cardiol
descriptionNiacin treatment (alone) was compared with etofibrate and niacin combination to treat patients with high-density lipoprotein <35 mg/dl and without hypertriglyceridemia. The niacin and etofibrate combination proved to be safe and increased high-density lipoprotein cholesterol levels to 48%, which was 3 times higher than that obtained with niacin alone.
subject
0Anticholesteremic Agents - administration & dosage
1Anticholesteremic Agents - therapeutic use
2Cholesterol, HDL - blood
3Clofibric Acid - administration & dosage
4Clofibric Acid - analogs & derivatives
5Clofibric Acid - therapeutic use
6Coronary Disease - blood
7Coronary Disease - drug therapy
8Delayed-Action Preparations
9Drug Administration Schedule
10Drug Synergism
11Female
12Humans
13Lipids - blood
14Male
15Middle Aged
16Niacin - administration & dosage
17Niacin - therapeutic use
18Time Factors
19Treatment Outcome
issn
00002-9149
11879-1913
fulltexttrue
rsrctypearticle
creationdate1999
recordtypearticle
recordideNqFkNtKAzEQhoMoWquPoORSL1Yzm-5uFgSR4gkEL9TrkMOsjWw3JUmVPoTvbGxFvBMGhoHvn0k-Qo6AnQGD-vyJMVYWLUzak1acMtaIpqi2yAhE0xbQAt8mo19kj-zH-JZHgKreJXuQed60MCKf112HJlHf0cEp4waqBksx-c7poBJSFaM3TiXnB5orLvVb5iP9cGlGjQ9-UGFFVUiYm3URVcT1johhOacz9zorLA7RpRXt3cIvgk-Yz5iZ7zHmlO_pBa_o_PXc9gdkp1N9xMOfPiYvN9fP07vi4fH2fnr1UBjOWCp4VRktyspA09UlWMuAIUe0hsOEaa5bjaWAup7wiS4704iMawGlQGtLo_mYVJu9JvgYA3ZyEdw8f0QCk9965Vqv_HYnWyHXemWVc8eb3GKp52j_pDY-M3C5ATC__t1hkNE4HAxaF7I2ab3758QXqhuNRg
startdate1999
enddate1999
creator
0Spósito, Andrei C
1Caramelli, Bruno
2Serrano, Carlos V
3Mansur, Antonio P
4Ramires, Jose A.F
generalElsevier Inc
scope
0CGR
1CUY
2CVF
3ECM
4EIF
5NPM
6AAYXX
7CITATION
sort
creationdate1999
titleEffect of niacin and etofibrate association on subjects with coronary artery disease and serum high-density lipoprotein cholesterol <35 mg/dl
authorSpósito, Andrei C ; Caramelli, Bruno ; Serrano, Carlos V ; Mansur, Antonio P ; Ramires, Jose A.F
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-c300t-355cb825c17f621dd010e3eedc3140b3b9be28166434b2fc78cb8b8128edd2cb3
rsrctypearticles
prefilterarticles
languageeng
creationdate1999
topic
0Anticholesteremic Agents - administration & dosage
1Anticholesteremic Agents - therapeutic use
2Cholesterol, HDL - blood
3Clofibric Acid - administration & dosage
4Clofibric Acid - analogs & derivatives
5Clofibric Acid - therapeutic use
6Coronary Disease - blood
7Coronary Disease - drug therapy
8Delayed-Action Preparations
9Drug Administration Schedule
10Drug Synergism
11Female
12Humans
13Lipids - blood
14Male
15Middle Aged
16Niacin - administration & dosage
17Niacin - therapeutic use
18Time Factors
19Treatment Outcome
toplevel
0peer_reviewed
1online_resources
creatorcontrib
0Spósito, Andrei C
1Caramelli, Bruno
2Serrano, Carlos V
3Mansur, Antonio P
4Ramires, Jose A.F
collection
0Medline
1MEDLINE
2MEDLINE (Ovid)
3MEDLINE
4MEDLINE
5PubMed
6CrossRef
jtitleThe American journal of cardiology
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
au
0Spósito, Andrei C
1Caramelli, Bruno
2Serrano, Carlos V
3Mansur, Antonio P
4Ramires, Jose A.F
formatjournal
genrearticle
ristypeJOUR
atitleEffect of niacin and etofibrate association on subjects with coronary artery disease and serum high-density lipoprotein cholesterol <35 mg/dl
jtitleThe American journal of cardiology
addtitleAm J Cardiol
date1999
risdate1999
volume83
issue1
spage98
epage100
pages98-100
issn0002-9149
eissn1879-1913
abstractNiacin treatment (alone) was compared with etofibrate and niacin combination to treat patients with high-density lipoprotein <35 mg/dl and without hypertriglyceridemia. The niacin and etofibrate combination proved to be safe and increased high-density lipoprotein cholesterol levels to 48%, which was 3 times higher than that obtained with niacin alone.
copUnited States
pubElsevier Inc
pmid10073791
doi10.1016/S0002-9149(98)00787-5